Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
Authors
Keywords
-
Journal
ACTA NEUROPSYCHIATRICA
Volume 29, Issue 05, Pages 278-290
Publisher
Cambridge University Press (CUP)
Online
2016-11-16
DOI
10.1017/neu.2016.57
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia
- (2016) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
- (2015) Christoph U. Correll et al. AMERICAN JOURNAL OF PSYCHIATRY
- A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
- (2015) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
- (2014) Suresh Durgam et al. BIPOLAR DISORDERS
- Validity of subjective versus objective quality of life assessment in people with schizophrenia
- (2014) Karen P Hayhurst et al. BMC Psychiatry
- “First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects
- (2014) Su Ling Young et al. JOURNAL OF PSYCHOPHARMACOLOGY
- 5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis
- (2013) Zacharias G. Laoutidis et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo
- (2013) Stephen M. Stahl et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Assessment of the minimum clinically important difference in quality of life in schizophrenia measured by the Quality of Well-Being Scale and disease-specific measures
- (2013) Soe Soe Thwin et al. PSYCHIATRY RESEARCH
- Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: A CATIE analysis
- (2013) Jonathan Rabinowitz et al. SCHIZOPHRENIA RESEARCH
- Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
- (2013) José M Olivares et al. Annals of General Psychiatry
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
- (2012) Marc De Hert et al. CNS DRUGS
- Drug safety assessment in clinical trials: methodological challenges and opportunities
- (2012) Sonal Singh et al. Trials
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
- (2009) Jan Volavka et al. EXPERT OPINION ON PHARMACOTHERAPY
- Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia
- (2008) Henry Nasrallah et al. PSYCHIATRY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More